Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 10.28M | 8.91M | 9.42M | 21.91%34.19M | 26.65%28.05M | 20.39%22.15M | 18.4M |
| Cost of revenue | 7M | 6.29M | 6.45M | 46.46%19.77M | -6.68%13.5M | 14.83%14.46M | 12.6M |
| Gross profit | 3.28M | 2.62M | 2.98M | -0.87%14.42M | 89.40%14.55M | 32.47%7.68M | 5.8M |
| Operating expense | 2.24M | 1.84M | 2.48M | 24.64%6.33M | 53.57%5.08M | -5.12%3.31M | 3.48M |
| Staff costs | ---- | ---- | ---- | 36.78%3.21M | 15.20%2.35M | -5.34%2.04M | --2.15M |
| Selling and administrative expenses | --2.24M | --1.84M | --2.48M | -8.40%1.76M | 191.63%1.92M | -8.98%658.17K | --723.08K |
| -Selling and marketing expense | --125K | --135K | --67K | 3.04%228.16K | 70.10%221.43K | -18.17%130.17K | --159.08K |
| -General and administrative expense | --2.11M | --1.71M | --2.42M | -9.89%1.53M | 221.59%1.7M | -6.38%528K | --564K |
| Depreciation and amortization | ---- | ---- | ---- | 68.06%1.28M | 23.03%764K | 1.14%621K | --614K |
| -Depreciation | ---- | ---- | ---- | 68.06%1.28M | 23.03%764K | 1.14%621K | --614K |
| Other operating expenses | ---- | ---- | ---- | 63.37%71.74K | 455.50%43.91K | -370.55%-12.35K | ---2.63K |
| Total other operating income | ---- | ---- | ---- | --0 | --0 | -95.35%200 | --4.3K |
| Operating profit | 1.04M | 779K | 492K | -14.54%8.1M | 116.46%9.47M | 89.06%4.38M | 2.31M |
| Net non-operating interest income (expenses) | -176K | -215K | -234K | -93.98%-966.97K | -63.15%-498.49K | 10.91%-305.54K | -342.96K |
| Non-operating interest income | ---- | ---- | ---- | 3.27%37.34K | 208.77%36.16K | 23,320.00%11.71K | --50 |
| Non-operating interest expense | --176K | --215K | --234K | 87.84%1M | 68.52%534.65K | -7.51%317.25K | --343.01K |
| Net investment income | -95.12%53.79K | 1.1M | 19.11K | ||||
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | |||||||
| Income from associates and other participating interests | |||||||
| Special income (charges) | 0 | 103.45K | 0 | 242.25K | |||
| Less:Impairment of capital assets | ---- | ---- | ---- | --0 | --102K | --0 | --0 |
| Less:Other special charges | ---- | ---- | ---- | ---- | ---205.45K | ---- | ---242.25K |
| Other non-operating income (expenses) | 552K | 453K | 441K | -22.83%1.5M | 1,146.70%1.94M | 116.63%155.4K | 71.74K |
| Income before tax | 1.42M | 1.02M | 699K | -28.38%8.68M | 186.71%12.12M | 83.34%4.23M | 2.31M |
| Income tax | 284K | 196K | 147K | -118.61%-579.97K | 197.76%3.12M | 60.18%1.05M | 653.49K |
| Net income | 1.14M | 821K | 552K | 2.86%9.26M | 183.08%9M | 92.51%3.18M | 1.65M |
| Net income continuous operations | --1.14M | --821K | --552K | 2.86%9.26M | 183.08%9M | 92.51%3.18M | --1.65M |
| Noncontrolling interests | |||||||
| Net income attributable to the company | 1.14M | 821K | 552K | 2.86%9.26M | 183.08%9M | 92.51%3.18M | 1.65M |
| Preferred stock dividends | |||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 1.14M | 821K | 552K | 2.86%9.26M | 183.08%9M | 92.51%3.18M | 1.65M |
| Gross dividend payment | |||||||
| Basic earnings per share | 0.002 | 0.0015 | 0.0011 | 2.87%0.0154 | 183.07%0.015 | 92.48%0.0053 | 0.0028 |
| Diluted earnings per share | 0.002 | 0.0015 | 0.0011 | 2.87%0.0154 | 183.07%0.015 | 92.48%0.0053 | 0.0028 |
| Dividend per share | |||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.